Can artificial intelligence lower the global sudden cardiac death rate? A narrative review

Raja Savanth Reddy Chityala1, Sandhya Bishwakarma2, Kaival Malav Shah3

  • 1Kamineni Institute of Medical Sciences (KNR University Health Sciences) Narketpally, India.

PubMed

Insights

Artificial intelligence (AI) shows promise in predicting sudden cardiac arrest (SCA) to improve survival rates. Further research is needed to optimize AI models for clinical application in SCA prevention.

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Medical Informatics

Background:

  • Sudden cardiac arrest (SCA) is a significant global cause of mortality.
  • Current survival rates for SCA remain low, underscoring the need for improved prediction and prevention strategies.
  • The World Health Organization (WHO) defines sudden cardiac death (SCD) based on timeframes relative to symptom onset or observation of the individual.

Purpose of the Study:

  • To review the current applications of Artificial Intelligence (AI) in predicting and preventing sudden cardiac arrest (SCA).
  • To explore the potential of AI, machine learning (ML), and deep learning (DL) in identifying individuals at risk for SCA.

Main Methods:

  • A literature search was conducted using PubMed and Web of Science databases.
  • Studies were included if they focused on sudden cardiac death prediction and prevention, and utilized artificial intelligence, machine learning, or deep learning techniques.

Main Results:

  • AI, ML, and DL demonstrate significant potential for risk stratification in SCA.
  • These technologies can aid in identifying individuals at higher risk of experiencing SCA.
  • Current AI models require further development and validation for widespread clinical use.

Conclusions:

  • AI, ML, and DL offer promising avenues for improving SCA survival rates through enhanced risk stratification.
  • Further research is essential, focusing on explainable AI, larger and diverse datasets, external validation, multimodal approaches, and ethical considerations.
  • Addressing bias and ensuring robust testing are critical steps to fully realize the potential of AI in SCA prevention.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
632
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.7K